FDA product code · Cardiovascular
Dual Lumen Ecmo Cannula
4 FDA decisions since 2017. 510(k) reviews decided 2021–2025 took a median of 108 days (half between 80 and 137). No recall names this code. The most-cited predicate is K180151, named by 2 later devices.
Long term support greater than 6 hours for acute respiratory or acute cardiopulmonary failure, where other available treatment options have failed, and continued clinical deterioration is expected or the risk of death is imminent.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly Download the data (CSV)
Twenty years of PZS at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.
FDA decisions per year · PZS
1in 2023
2026 to Oct 25, outlined.
Median 510(k) review, days · PZS
Too few PZS 510(k)s in any year since 2007 to give a median.
Recalls per year · PZS
No recall names PZS since 2007.
Adverse event reports per year · PZS
34in 2025
MAUDE reports naming product code PZS, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 1 | — | 0 | 0 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 1 |
| 2020 | 0 | — | 0 | 6 |
| 2021 | 1 | — | 0 | 12 |
| 2022 | 0 | — | 0 | 28 |
| 2023 | 1 | — | 0 | 10 |
| 2024 | 0 | — | 0 | 11 |
| 2025 | 0 | — | 0 | 34 |
| 2026 | 0 | — | 0 | — |
Planning a device in PZS? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportRelated product codes
Other codes under 21 CFR 870.4100.